APPLICATION
ANDA203924
TYPE
ANDA
ORIGINAL APPROVAL
2014-02-03
LATEST ACTION
2025-08-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
PRIMAQUINE PHOSPHATEDiscontinued
PRIMAQUINE PHOSPHATE EQ 15MG BASE · TABLET · ORAL
Approval history
2025-08-15Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.